Antibody therapy for rheumatoid arthritis.

High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...

Mô tả đầy đủ

Chi tiết về thư mục
Tác giả chính: Taylor, P
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2003